| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3613 | |||||||||||||||||||||||
| Submitter : | Mrs. Judy Ashby | Date & Time: | 12/19/2006 09:12:58 | |||||||||||||||||||||
| Organization : | Mrs. Judy Ashby | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I do not believe that it is ethical for us to use aborted fetal cell lines for future vaccine development by the pharmaceutical industry. The killing of fetuses is not ethical and we should not use these cells. There are alternative cell lines that can be used for this purpose. Thank you. | ||||||||||||||||||||||||